These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 12084530

  • 1. Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods.
    Beretta E, Dhillon H, Kalra PS, Kalra SP.
    Peptides; 2002 May; 23(5):975-84. PubMed ID: 12084530
    [Abstract] [Full Text] [Related]

  • 2. Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study.
    Dhillon H, Kalra SP, Prima V, Zolotukhin S, Scarpace PJ, Moldawer LL, Muzyczka N, Kalra PS.
    Regul Pept; 2001 Jun 15; 99(2-3):69-77. PubMed ID: 11384767
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus.
    Dhillon H, Kalra SP, Kalra PS.
    Mol Ther; 2001 Aug 15; 4(2):139-45. PubMed ID: 11482985
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels.
    Dube MG, Beretta E, Dhillon H, Ueno N, Kalra PS, Kalra SP.
    Diabetes; 2002 Jun 15; 51(6):1729-36. PubMed ID: 12031959
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased leptin expression in the dorsal vagal complex suppresses adiposity without affecting energy intake and metabolic hormones.
    Boghossian S, Lecklin A, Dube MG, Kalra PS, Kalra SP.
    Obesity (Silver Spring); 2006 Jun 15; 14(6):1003-9. PubMed ID: 16861605
    [Abstract] [Full Text] [Related]

  • 14. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system.
    Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Yoshimasa Y, Nakao K.
    Neurosci Lett; 1998 Jun 19; 249(2-3):107-10. PubMed ID: 9682828
    [Abstract] [Full Text] [Related]

  • 15. Effects of chronic murine and human leptin infusion on plasma leptin and corticosterone levels and energy balance in lean Zucker rats.
    Al-Barazanji KA, Buckingham RE, Arch JR, Briscoe C, Jenkins O, Tadayyon M.
    Diabetes Obes Metab; 2001 Dec 19; 3(6):435-42. PubMed ID: 11903416
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice.
    Masaki T, Yoshimatsu H, Chiba S, Watanabe T, Sakata T.
    Diabetes; 2001 Feb 19; 50(2):376-84. PubMed ID: 11272150
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.